Similar to This
Previous

AstraZeneca and BMS: Why the biggest deal in history is surprising: The British pharmaceutical company AstraZeneca and its US competitor Bristol Myers Squibb are ...
wiwo.de/finanzen/boerse/astrazeneca-und-bms-deshalb-kommtgroesste-deal-der-geschichte-ueberraschend/100244645.html

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’: Europe and US risk being outpaced on innovation, as happened in the car industry ...
theguardian.com/business/2026/jul/27/astrazeneca-boss-urges-western-drugmakers-to-move-at-chinese-speed

Prozess um brutale Schlägerei in Hannovers Rotlichtviertel: Türsteher zu Bewährungsstrafe verurteilt
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-magic-faces-rare-test-after-trial-failure-share-slide-2026-07-24/
AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE
qz.com/astrazeneca-ceo-pascal-soriot-nyse-transfer

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
cnbc.com/2026/06/05/astrazeneca-ceo-says-ai-is-reshaping-drug-development-and-helping-boost-the-odds-of-success.html

AstraZeneca CEO: “If prices are too low, we won’t bring the drugs to market”: Pascal Soriot, CEO of the pharmaceutical company AstraZeneca, is threatening to ...
wiwo.de/unternehmen/industrie/astrazeneca-chef-sind-die-preise-zu-niedrig-bringen-wir-die-medikamente-nicht-auf-den-markt/100218667.html

Dividend guarantor AstraZeneca keeps growing – pharmaceutical giant on track: AstraZeneca exceeds expectations with Q3 growth and confirms targets for 2030.
deraktionaer.de/artikel/pharma-biotech/dividenden-garant-astrazeneca-waechst-und-waechst-pharma-riese-auf-kurs-20389877.html

NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss: Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed ...
theguardian.com/business/2025/nov/06/uk-will-only-be-able-to-afford-generic-drugs-if-nhs-fails-to-pay-more-says-astrazeneca-boss

AstraZeneca’s listing rejig spells long-term danger for London: It’s not skipping off entirely to New York, but pharma giant sets a worrying precedent for UK ...
theguardian.com/business/nils-pratley-on-finance/2025/sep/29/astrazenecas-listing-rejig-spells-long-term-danger-for-london

Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London
theguardian.com/business/nils-pratley-on-finance/2025/jul/29/ministers-now-is-the-moment-to-fight-to-keep-astrazeneca-london-listing

AstraZeneca pledges $50bn investment in the US amid 200% tariff fears: British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in ...
euronews.com/business/2025/07/22/astrazeneca-pledges-50bn-investment-in-the-us-amid-200-tariff-fears

Astrazeneca chief ‘wants to shift London listing to US’: The boss of Astrazeneca has reportedly voiced his desire to transfer the pharma giant's listing to the ...
cityam.com/astrazeneca-chief-wants-to-shift-listing-to-us/

AstraZeneca boss ‘wants to shift stock market listing to US’: Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company ...
theguardian.com/business/2025/jul/01/astrazeneca-boss-wants-to-shift-stock-market-listing-to-us

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs: UK and rest of Europe risk losing out to US and China unless they ramp up spending on new ...
theguardian.com/business/2025/apr/29/astrazeneca-production-us-trump-tariffs-uk-europe-pascal-soriot

Paid articlePaywall Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?: Pascal Soriot was already the highest-paid leader of a FTSE 100 company ...
independent.co.uk/independentpremium/business/astrazeneca-salary-pascal-soriot-b2527111.html

AstraZeneca CEO set to earn £18.7 million after shareholder backing: More than 60% of shareholders backed the decision to raise Pascal Soriot’s pay packet ...
euronews.com/business/2024/04/12/astrazeneca-ceo-set-to-earn-187-million-after-shareholder-backing

Top chief execs ‘paid more in a year than a UK worker gets in a lifetime’: Despite a fall in remuneration during the Covid pandemic, blue chip company bosses ...
theguardian.com/business/2021/aug/19/top-chief-execs-paid-more-in-a-year-than-a-uk-worker-gets-in-a-lifetime

Head of Covid vaccine maker AstraZeneca tops CEO pay chart in UK with $18 million
wionews.com/world/head-of-covid-vaccine-maker-astrazeneca-tops-ceo-pay-chart-in-uk-with-18-million-406725

Will the AstraZeneca share price be the largest FTSE 100 riser in 2021? - The Motley Fool UK
fool.co.uk/investing/2020/12/29/will-the-astrazeneca-share-price-be-the-largest-ftse-100-riser-in-2021/
Next

